SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-072642
Filing Date
2023-12-22
Accepted
2023-12-22 16:15:11
Documents
12
Period of Report
2023-12-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K drrx-20231221.htm   iXBRL 8-K 42841
  Complete submission text file 0000950170-23-072642.txt   163094

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT drrx-20231221_lab.xml EX-101.LAB 17193
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT drrx-20231221_pre.xml EX-101.PRE 10669
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT drrx-20231221.xsd EX-101.SCH 2468
6 EXTRACTED XBRL INSTANCE DOCUMENT drrx-20231221_htm.xml XML 4510
Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB ROAD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31615 | Film No.: 231509947
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)